These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 6314572)

  • 1. The first component of human complement (C1): activation and control.
    Ziccardi RJ
    Springer Semin Immunopathol; 1983; 6(2-3):213-30. PubMed ID: 6314572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of immune complexes in the activation of the first component of human complement.
    Ziccardi RJ
    J Immunol; 1984 Jan; 132(1):283-8. PubMed ID: 6317744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-independent activation of C1. I. Differences in the mechanism of C1 activation by nonimmune activators and by immune complexes: C1r-independent activation of C1s by cardiolipin vesicles.
    Kovacsovics TJ; Peitsch MC; Kress A; Isliker H
    J Immunol; 1987 Mar; 138(6):1864-70. PubMed ID: 3029222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of C1.
    Colomb MG; Arlaud GJ; Villiers CL
    Philos Trans R Soc Lond B Biol Sci; 1984 Sep; 306(1129):283-92. PubMed ID: 6149573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous activation of the first component of human complement (C1) by an intramolecular autocatalytic mechanism.
    Ziccardi RJ
    J Immunol; 1982 Jun; 128(6):2500-4. PubMed ID: 6281332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FN-C1q and C1 INH C1r-C1s complexes as indicators of complement activation in patients with chronic lymphocytic leukaemia.
    Hidvégi T; Ermolin GA; Efremov EE; Dikov MM; Kurmanova LV; Vnashenkova GV; Merkulova MV; Kókai M; Panya A; Füst G
    Immunol Lett; 1989 Jul; 22(1):1-6. PubMed ID: 2550362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A molecular mechanism for the activation of the first component of complement by immune complexes.
    Schumaker VN; Hanson DC; Kilchherr E; Phillips ML; Poon PH
    Mol Immunol; 1986 May; 23(5):557-65. PubMed ID: 3018553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nature of the interaction between the C1q and C1r2S2 subunits of the first component of human complement.
    Ziccardi RJ
    Mol Immunol; 1985 Apr; 22(4):489-94. PubMed ID: 2993872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.
    Thielens NM; Illy C; Bally IM; Arlaud GJ
    Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):509-16. PubMed ID: 8042996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nature of the metal ion requirement for assembly and function of the first component of human complement.
    Ziccardi RJ
    J Biol Chem; 1983 May; 258(10):6187-92. PubMed ID: 6304029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation of C1 and concentration dependence of its activation kinetics.
    Kilchherr E; Fuchs H; Tschopp J; Engel J
    Mol Immunol; 1982 May; 19(5):683-91. PubMed ID: 6287243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
    Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
    J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of activation of C1, despite circulating immune complexes detected by two C1q methods, in patients with rheumatoid arthritis.
    Hack CE; Eerenberg-Belmer AJ; Lim UG; Haverman J; Aalberse RC
    Arthritis Rheum; 1984 Jan; 27(1):40-8. PubMed ID: 6318777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody density on rat red cells determines the rate of activation of the complement component C1.
    Hughes-Jones NC; Gorick BD; Howard JC; Feinstein A
    Eur J Immunol; 1985 Oct; 15(10):976-80. PubMed ID: 2996908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement components, C1 activation and disease activity in SLE.
    Sturfelt G; Sjöholm AG; Svensson B
    Int Arch Allergy Appl Immunol; 1983; 70(1):12-8. PubMed ID: 6293980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational changes of the subunits C1q, C1r and C1s of human complement component C1 demonstrated by 125I labeling.
    Bauer J; Valet G
    Biochim Biophys Acta; 1981 Aug; 670(1):129-33. PubMed ID: 6268178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and activation of C1, the complex initiating the classical pathway of the complement cascade.
    Mortensen SA; Sander B; Jensen RK; Pedersen JS; Golas MM; Jensenius JC; Hansen AG; Thiel S; Andersen GR
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):986-991. PubMed ID: 28104818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human complement subcomponent C1s lacking beta-hydroxyasparagine, sialic acid, and one of its two carbohydrate chains still reassembles with C1q and C1r to form a functional C1 complex.
    Luo C; Thielens NM; Gagnon J; Gal P; Sarvari M; Tseng Y; Tosi M; Zavodszky P; Arlaud GJ; Schumaker VN
    Biochemistry; 1992 May; 31(17):4254-62. PubMed ID: 1533159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.